BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37833867)

  • 1. Cell-Type-Specific Mitochondrial Quality Control in the Brain: A Plausible Mechanism of Neurodegeneration.
    Ragupathy H; Vukku M; Barodia SK
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Death Mechanisms of Neurodegeneration.
    Fan J; Dawson TM; Dawson VL
    Adv Neurobiol; 2017; 15():403-425. PubMed ID: 28674991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia-Specific Metabolic Changes in Neurodegeneration.
    Aldana BI
    J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte-Neuron Metabolic Crosstalk in Neurodegeneration: A Mitochondrial Perspective.
    Mulica P; Grünewald A; Pereira SL
    Front Endocrinol (Lausanne); 2021; 12():668517. PubMed ID: 34025580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial mitochondrial function and dysfunction in health and neurodegeneration.
    McAvoy K; Kawamata H
    Mol Cell Neurosci; 2019 Dec; 101():103417. PubMed ID: 31678567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteotoxicity and mitochondrial dynamics in aging diabetic brain.
    Fernandes V; Choudhary M; Kumar A; Singh SB
    Pharmacol Res; 2020 Sep; 159():104948. PubMed ID: 32450345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury.
    Gollihue JL; Norris CM
    Ageing Res Rev; 2020 May; 59():101039. PubMed ID: 32105849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issue.
    Rodríguez MJ; Martínez-Moreno M; Ortega FJ; Mahy N
    Oxid Med Cell Longev; 2013; 2013():194546. PubMed ID: 23844272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal Mitochondria Modulation of LPS-Induced Neuroinflammation.
    Harland M; Torres S; Liu J; Wang X
    J Neurosci; 2020 Feb; 40(8):1756-1765. PubMed ID: 31937559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
    Millichap LE; Damiani E; Tiano L; Hargreaves IP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mitochondrial ROS in the brain: from physiology to neurodegeneration.
    Angelova PR; Abramov AY
    FEBS Lett; 2018 Mar; 592(5):692-702. PubMed ID: 29292494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism.
    Ke ZJ; Gibson GE
    Neurochem Int; 2004; 45(2-3):361-9. PubMed ID: 15145550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria dysregulation contributes to secondary neurodegeneration progression post-contusion injury in human 3D in vitro triculture brain tissue model.
    Liaudanskaya V; Fiore NJ; Zhang Y; Milton Y; Kelly MF; Coe M; Barreiro A; Rose VK; Shapiro MR; Mullis AS; Shevzov-Zebrun A; Blurton-Jones M; Whalen MJ; Symes AJ; Georgakoudi I; Nieland TJF; Kaplan DL
    Cell Death Dis; 2023 Aug; 14(8):496. PubMed ID: 37537168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.
    Marzetti E; Csiszar A; Dutta D; Balagopal G; Calvani R; Leeuwenburgh C
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H459-76. PubMed ID: 23748424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria at the interface between neurodegeneration and neuroinflammation.
    Bader V; Winklhofer KF
    Semin Cell Dev Biol; 2020 Mar; 99():163-171. PubMed ID: 31154011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases.
    Huang C; Yan S; Zhang Z
    Transl Neurodegener; 2020 Oct; 9(1):40. PubMed ID: 33126923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
    Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial fusion/fission dynamics in neurodegeneration and neuronal plasticity.
    Bertholet AM; Delerue T; Millet AM; Moulis MF; David C; Daloyau M; Arnauné-Pelloquin L; Davezac N; Mils V; Miquel MC; Rojo M; Belenguer P
    Neurobiol Dis; 2016 Jun; 90():3-19. PubMed ID: 26494254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.